1,3,4-thiadiazole has been researched along with Leishmaniasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alipour, E; Ardestani, SK; Emami, S; Foroumadi, A; Hosseini, M; Johari, F; Nakhjiri, M; Poorrajab, F; Shafiee, A; Yahya-Meymandi, A | 1 |
Forouzannia, SK; Pourrajab, F; Tabatabaee, SA | 1 |
2 other study(ies) available for 1,3,4-thiadiazole and Leishmaniasis
Article | Year |
---|---|
Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles.
Topics: Antiprotozoal Agents; Cell Culture Techniques; Humans; Inhibitory Concentration 50; Leishmania major; Leishmaniasis; Nitro Compounds; Structure-Activity Relationship; Tetrazolium Salts; Thiadiazoles; Thiazoles | 2011 |
Novel immunomodulatory function of 1,3,4-thiadiazole derivatives with leishmanicidal activity.
Topics: Animals; Antiprotozoal Agents; Cytokines; Disease Models, Animal; Histocytochemistry; Immunologic Factors; Injections, Intraperitoneal; Leishmaniasis; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Skin; Spleen; Thiadiazoles; Treatment Outcome | 2012 |